ATS Medical, Inc. (NASDAQ: ATSI) is focused on providing novel products and services designed specifically for cardiac surgery. Over 160,000 ATS Open Pivot(R) Heart Valves have been implanted in patients around the globe. ATS’ 3f(R) brand includes multiple tissue heart valve product offerings at varying steps from market introductions and clinical trials to development projects that utilize less invasive valve replacement technology. For further information, visit the Company’s web site at www.atsmedical.com.
- 17 years ago
QualityStocks
ATS Medical, Inc. (NASDAQ: ATSI)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Featured in NetworkNewsWire Editorial on AI-Driven Breast Cancer Imaging
Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) announced its inclusion in a NetworkNewsWire (“NNW”) editorial titled…
-
QualityStocksNewsBreaks – Forward Industries, Inc. (NASDAQ: FORD) Featured in Oak Ridge Financial Research Report Highlighting Transition to Solana Digital Asset Treasury Model
Forward Industries (NASDAQ: FORD) has been featured in a new research report by Oak Ridge…
-
QualityStocksNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Advances HyBryte(TM) as Potential First-Line CTCL Treatment with Promising FLASH Results
Soligenix (NASDAQ: SNGX) is continuing to build momentum in the treatment of early-stage cutaneous T-cell…